Author

Anna X.A. Wang

University of Illinois Urbana-Champaign

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Alisha Y. XiongiD· 1 shared Annika Carrillo· 1 shared Christopher J. FieldsiD· 1 shared Colin K.W. LimiD· 1 shared Daniel G. Renshaw· 1 shared Daniela Del Bosque SilleriD· 1 shared Jack He· 1 shared Katherine Tan· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alisha Y. XiongORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease

Katherine Tan, Daniela Del Bosque Siller, Alisha Y. Xiong, Anna X.A. Wang, Tristan X. McCallister, Sreya Mummadi, Luke A. St John, Tae Kyu Lee, Annika Carrillo, Daniel G. Renshaw, Richard H. Zhou, Colin K.W. Lim, Jack He, Christopher J. Fields, Michael R. Hayden, Thomas Gaj

This study develops a CRISPR-Cas9 system targeting all HTT alleles in HD mouse models, reducing mutant HTT and improving disease symptoms.

Molecular Therapy · Apr 24, 2026Peer-reviewedBioengineering